Anatase and rutile titanium oxide nanoparticles induce acute kidney injury by coadministration with paraquat, cisplatin or 5-aminosalicylic acid

Nanoparticles are used in a variety of fields; for example, titanium oxide nanoparticles are used in paints, food additives, cosmetics, and sunscreen materials. Although the use of titanium oxide nanoparticles is regulated, their safety has not been established. Furthermore, the interaction between titanium oxide nanoparticles and various chemical substances and pharmaceuticals is unknown. We co-administered rutile-type titanium oxide nanoparticles (nTR) or anatase-type titanium oxide nanoparticles (nTA) to mice together with paraquat (PQ), cisplatin (CDDP), or anti-5-aminosalicylic acid (5-ASA), and investigated the extent, if any, of liver and kidney injury. As a result, when nTA and nTR were administered alone, no increases were observed in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are indicators of liver damage, or urea nitrogen (BUN), which is an indicator of kidney damage. Next, nTA and nTR were co-administered with PQ, CDDP or 5-ASA. Although no increase in ALT or AST was observed, BUN levels increased significantly and acute kidney injury was induced. The findings suggested that titanium oxide nanoparticles induce acute kidney injury through their interaction with chemicals and drugs.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:79

Enthalten in:

Die Pharmazie - 79(2024), 1 vom: 29. Feb., Seite 2-5

Sprache:

Englisch

Beteiligte Personen:

Kamiyama, H [VerfasserIn]
Nonaka, C [VerfasserIn]
Saitoh, H [VerfasserIn]
Ohno, M [VerfasserIn]
Shimizu, Y [VerfasserIn]
Isoda, K [VerfasserIn]

Links:

Volltext

Themen:

15FIX9V2JP
4Q81I59GXC
Cisplatin
D1JT611TNE
Journal Article
Mesalamine
PLG39H7695
Paraquat
Q20Q21Q62J
Titanium
Titanium dioxide

Anmerkungen:

Date Completed 22.03.2024

Date Revised 05.04.2024

published: Print

Citation Status MEDLINE

doi:

10.1691/ph.2024.3655

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369992105